Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Meningococcemia, Emergency Medicine


Basics


Description


  • Bacterial illness caused by Neisseria meningitidis
  • Several forms of illness may occur
  • Mild meningococcemia
  • Overwhelming meningococcal sepsis
  • Meningococcal meningitis
  • Chronic/occult meningococcemia
  • Septic arthritis
  • Acquired from close contact with an infected individual or an asymptomatic carrier
  • Intimate kissing and cigarette smoking are independent risk factors.

Etiology


  • N. meningitidis:
    • Serotypes A, B, C, D, H, I, K, L, X, Y, Z, 29E, and W135
    • Serotype B is most common in US
    • Majority of infections caused by A, B, C, X, Y, and W135
  • Bacteria attach to and enter nasopharyngeal epithelial cells.
  • Bacteria spread from the nasopharynx through the bloodstream via entry of vascular endothelium.
  • Most circulating meningococci are eliminated by the spleen.
  • Meningococci produce an endotoxin (lipooligosaccharide):
    • Involved in pathogenesis of the skin, adrenal manifestations, and vascular collapse
  • Human oropharynx/nasopharynx is the only reservoir.
  • Carrier usually has developed immunity to serotype-specific antibody (not immune to all serotypes):
    • Age <5 yr: 1% carrier rate
    • Age 20 " “40 yr: 30 " “40% carrier rate
    • Lower rate of immunity in children, which is reflected by the higher rates of infection
  • Most common in fall and spring
  • Increased incidence in military recruits and close living conditions
  • Epidemics " ”ages 5 " “9 yr most/earliest affected

Diagnosis


Signs and Symptoms


  • "Mild "  meningococcemia:
    • Most common
    • Preceded by upper respiratory infection
    • Fever, chills, myalgias/arthralgias, malaise
    • Often self-limited, resolving in several days
    • Can progress to meningitis (mortality rate 2 " “10%) or overwhelming sepsis without meningitis
  • Overwhelming meningococcal sepsis:
    • 10% of overall meningococcemia cases
    • High mortality rate (20 " “60%)
    • Most deaths occur in 1st 48 hr
    • Sudden onset of illness and rapid progression of clinical course
    • Initial presentation may be mild:
      • Mild tachycardia
      • Mild tachypnea/respiratory symptoms
      • Mild hypotension
    • Fever, chills, vomiting, headache, rash, muscle tenderness
    • Toxic appearing
    • Infants: Lethargy, poor feeding, bulging fontanel
    • Rash:
      • Combination of purpura/ecchymosis
      • May later exhibit coalescence, necrosis/sloughing of the involved skin (purpura fulminans)
      • Petechiae (over skin, mucous membranes, conjunctivae) seen in 50 " “60%
      • Macules
      • Papules (scrapings of papules demonstrate the organism on Gram stain)
    • Deteriorate quickly over several hours:
      • Hypotension/shock
      • Acidosis
      • Acute respiratory distress syndrome (ARDS)
      • Disseminated intravascular coagulation (DIC)
    • Meningitis may or may not be present.
    • Waterhouse " “Friderichsen syndrome:
      • Bilateral hemorrhagic destruction of adrenal glands
      • Vasomotor collapse
    • Acute renal failure:
      • From prolonged hypotension (low renal perfusion causing acute tubular necrosis)
  • Chronic meningococcemia:
    • Uncommon
    • Well appearing
    • Recurrent fevers, chills, arthralgias over weeks to months
    • Intermittent rash " ”painful on the extremities
    • Migratory polyarthritis
    • Splenomegaly (20%)
    • Meningococcal meningitis:
    • Headache
    • Fever
    • Neck stiffness
    • Confusion
    • Lethargy
    • Obtundation
  • Septic arthritis:
    • Occurs during active meningococcemia
    • Multiple joints involved
    • Joint pain, redness, swelling, effusion, fever, chills
    • Extremely limited or no range of motion
  • Other meningococcal infections:
    • Occur with meningococcal infection elsewhere
    • Conjunctivitis " ”may occur alone
    • Sinusitis
    • Panophthalmitis
    • Urethritis
    • Salpingitis
    • Prostatitis
    • Pneumonia
    • Myocarditis/pericarditis:
      • Occurs late in onset
      • Usually associated with serogroup C

History
Progression of illness is variable and classifies illness into mild, overwhelming, and chronic. ‚  
Physical Exam
  • Tachycardia
  • Hypotension, which may be mild initially
  • Progressive, rapid deterioration
  • Respiratory failure with ARDS picture
  • Petechial rash 50 " “80%:
    • Involves axillae, flanks, wrists, ankles

Essential Workup


  • Do not allow workup (including delay in lumbar puncture) to postpone resuscitation and administration of antibiotics in suspected cases of meningococcemia.
  • Suspect diagnosis in setting of dramatic clinical presentation.
  • Gram stain and culture of:
    • Peripheral blood, CSF, sputum, urine, joint aspirate, or petechial/papular scrapings
    • Gram stain: Intracellular or extracellular gram-negative diplococci

Diagnosis Tests & Interpretation


Lab
  • CBC:
    • Elevated WBCs initially; later may be suppressed in severe disease
    • Decreased platelet count when large areas of purpura/petechiae or DIC
  • Electrolytes, BUN, creatinine, glucose
  • CSF:
    • Gram stain, culture, protein and glucose, cell count with differential
    • Consistent with bacterial infection in meningococcal meningitis
  • Arterial blood gases for acidosis, hypoxia
  • Fibrinogen levels, fibrin degradation products, prothrombin time, partial thromboplastin time if DIC suspected
  • Throat/nasopharyngeal swab:
    • Positive swab does not establish the diagnosis of meningococcemia.
  • Analysis of buffy-coat layer of peripheral blood for bacteria if sepsis is suspected
  • Blood culture:
    • Often negative with chronic meningococcemia
    • Positive in mild and overwhelming meningococcemia
  • Immunoassays (beware false negatives)
  • Polymerase chain reaction, especially useful when antibiotics given before specimen collection

Imaging
CXR: For ARDS/pneumonia ‚  
Diagnostic Procedures/Surgery
Amputations and debridement of necrotic tissue and/or extremities may be necessary. ‚  

Differential Diagnosis


  • Viral exanthem
  • Vasculitis
  • Mycoplasma
  • Rocky Mountain spotted fever
  • Toxic shock syndrome
  • Henoch " “Sch ƒ Άnlein purpura
  • Idiopathic thrombocytopenic purpura
  • Dengue fever
  • Disseminated gonococcal infection
  • Influenza
  • Streptococcus group A and B
  • Thrombotic thrombocytopenic purpura

Treatment


Pre-Hospital


Postexposure prophylaxis needed for pre-hospital personnel in close contact with patient ‚  

Initial Stabilization/Therapy


  • Wear mask and gloves, observe droplet precautions.
  • Notify department of health.
  • ABCs
  • Immediate endotracheal intubation for severe acidosis, hypoxia, or decreased mental status:
    • Hyperventilate to treat acidosis (target PCO2 about 25 mm Hg)
  • Treat hypotension:
    • 0.9% normal saline bolus of 20 mL/kg; cautious rehydration with ARDS, CHF
    • Begin dopamine or norepinephrine (epinephrine if no response) if hypotensive after 2 L of IV fluids.
  • Naloxone, thiamine, dextrose (Accu-Chek) for altered mental status
  • Initiate IV antibiotics:
    • 1st line: High-dose penicillin (proven meningococcemia) or 3rd-generation cephalosporin (broader coverage pending definitive diagnosis)
    • 2nd line: Ampicillin
    • 3rd line: Chloramphenicol (penicillin-allergic patients)

Ed Treatment/Procedures


  • Overwhelming meningococcal sepsis
  • Severe acidosis (pH <7 " “7.1 or serum HCO3 <8 " “10):
    • Administer IV NaHCO3 along with hyperventilation.
  • Insert Foley catheter to monitor urine output.
  • Place in respiratory isolation.
  • High-dose steroids:
    • To protect against cranial nerve injury in the setting of ongoing infection (controversial)
    • Administer with adrenal gland injury.
  • DIC treatment:
    • Administer fresh-frozen plasma and platelet transfusions.
    • Heparin is not indicated unless significant thrombotic complications are evident clinically (e.g., cyanosis or cold digits, low urine output despite adequate volume status, and blood pressure).
  • Prophylaxis options for close contacts:
    • Ideally, prophylaxis should be given within 1st 24 hr.
    • 10-day window of observation
    • Serogroup-specific vaccine as adjunct only
  • Vaccine:
    • Vaccine recommended in military recruits, travelers to endemic areas, complement-deficient or asplenic patients, 1st-year college dormitory residents
    • Vaccine recommended routinely for ages 11 " “18 yr

The safety of meningococcal vaccine is unclear in pregnancy. ‚  

Medication


First Line
  • Cefotaxime: 2 g (peds: 50 mg/kg) IV q6h
  • Ceftriaxone: 2 g (peds: 50 mg/kg) IV q12h
  • Penicillin G: 4 MU (peds: 250,000 U/kg/24 h) IV q4h

Second Line
  • Ampicillin: 2 " “3 g (peds: 200 " “400 mg/kg/24 h) IV q6h
  • Chloramphenicol: 50 " “100 mg/kg/24 h IV q6h (max. 4 g/d)
  • Prophylaxis:
    • Single-dose ceftriaxone:
      • 125 mg IM for age <15 yr
      • 250 mg IM for age >15 yr
    • Ciprofloxacin: 500 mg PO (adults)
    • Rifampin: 600 mg (peds: 5 " “10 mg/kg) PO BID for 2 days
    • Azithromycin 500 mg PO single dose (not routinely used)
  • Dexamethasone: 0.15 mg/kg IV for pediatric meningitis
  • Dopamine: 5 " “20 ug/kg/min IV titrate to blood pressure (BP)
  • Epinephrine: 2 " “10 ug/min IV titrate to BP
  • Heparin: 3,000 " “5,000 U (peds: 80 U/kg) IV bolus followed by 600 " “1,000 U/h (peds: 18 U/kg/h) IV drip
  • Hydrocortisone (Solu-Cortef): 100 mg (peds: 2 mg/kg) bolus IV for adrenal insufficiency q8h
  • Meningococcal polysaccharide 0.5 mL IM ƒ —1
  • Meningococcal vaccine 0.5 mL SC ƒ —1
  • Norepinephrine: 0.5 " “30 ug/min IV titrate to BP
  • Sodium bicarbonate: 2 " “5 mEq/kg (peds: 0.5 " “1 mEq/kg) IV over 30 min to 4 hr

Follow-Up


Disposition


Admission Criteria
  • ICU admission for overwhelming sepsis with respiratory isolation
  • Respiratory isolation admission for mild meningococcemia

Discharge Criteria
Prophylaxis for close patient contacts ‚  
Issues for Referral
  • Consider transfer to tertiary care center, as multisystem organ failure is common.
  • Late neurologic, cardiovascular, and orthopedic complications may necessitate follow-up with specialists.

Follow-Up Recommendations


  • Complete antibiotic course.
  • Respiratory precautions may be discontinued after 24 hr.
  • All close contacts need prophylaxis.

Pearls and Pitfalls


  • Notify department of health in any suspected case.
  • Watch for late development of pericardial tamponade.
  • Do not wait to give antibiotics.

Additional Reading


  • Apicella ‚  M. Neisseria meningitidis. In: Mandell ‚  GL, Bennett ‚  JE, Dolin ‚  R, eds. Principles and Practice of Infectious Disease. 7th ed. Philadelphia, PA: Churchill Livingston Elsevier; 2010:2737 " “2752.
  • Cramer ‚  JP, Wilder-Smith ‚  A. Meningococcal disease in travelers: Update on vaccine options. Curr Opin Infect Dis.  2012;25(5):507 " “517.
  • Pace ‚  D, Pollard ‚  AJ. Meningococcal disease: Clinical presentation and sequelae. Vaccine.  2012;30(suppl 2):B3 " “B9.
  • Rosenstein ‚  R, Perkins ‚  BA, Stephens ‚  DS, et al. Meningococcal disease. N Engl J Med.  2001;344(18):1378 " “1388.

See Also (Topic, Algorithm, Electronic Media Element)


  • Meningitis
  • Sepsis

Codes


ICD9


036.2 Meningococcemia ‚  

ICD10


  • A39.2 Acute meningococcemia
  • A39.3 Chronic meningococcemia
  • A39.4 Meningococcemia, unspecified

SNOMED


  • 4089001 Meningococcemia (disorder)
  • 186365005 Acute meningococcemia
  • 240426001 chronic meningococcemia (disorder)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer